SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-13-004147
Filing Date
2013-04-09
Accepted
2013-04-09 16:32:15
Documents
5
Period of Report
2013-05-30
Effectiveness Date
2013-04-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2214107zdef14a.htm DEF 14A 391319
2 G719808.JPG g719808.jpg GRAPHIC 8483
3 G847566.JPG g847566.jpg GRAPHIC 8495
4 G825221.JPG g825221.jpg GRAPHIC 7863
5 G621361.JPG g621361.jpg GRAPHIC 9211
  Complete submission text file 0001047469-13-004147.txt   439842
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-32966 | Film No.: 13751401
SIC: 2836 Biological Products, (No Diagnostic Substances)